Barry Olafson

Barry Olafson has been in the business world since 1983, when they co-founded Molecular Simulations Inc (formerly BioDesign). Barry served as the company's CEO until 2009, when they co-founded Protabit and took on the same role.

Barry Olafson obtained their PhD in Computational Chemistry, Metalloproteins from Caltech and then completed a PostDoc in Molecular Simulation (Karplus group) at Harvard.